Viewing nowWonsaltan Tablet (Losartan potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

MFDS item code 200401755 · Notified 2004.11.17 · Insurance code 671801400
Treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
This medication is used to treat hypertension. It specifically helps reduce the risk of kidney damage in hypertensive patients with type 2 diabetes. This role effectively controls blood pressure and protects kidney function. It is an important therapeutic option for improving patient health.
This medicine may be taken regardless of meals, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. Hypertension: If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual dose in adults is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular effective circulating volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh at least 20 kg but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause severe harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. Taking this medicine during pregnancy can lead to serious side effects such as reduced lung development in the fetus, skeletal deformities, decreased cranial formation, and decreased kidney function. Women who may become pregnant should not take this medication, and those planning to become pregnant should consult a doctor. Avoid this medication if there is an allergic reaction to it or serious liver impairment. Moreover, patients with hereditary angioedema or a history of angioedema, as well as those with primary hyperaldosteronism, should not use this medication. This medicine is not administered to patients with genetic problems that inhibit the breakdown of lactose. Patients with moderate to severe diabetes or renal impairment should avoid concomitant use of this medication with certain drugs. Elderly patients, those with hyperkalemia, and those with liver impairment should use this medication with caution; patients with valvular heart disease or ischemic heart disease also require careful attention. Patients with decreased blood volume or renal artery stenosis should be closely monitored when using this medication. This medication is generally safe; however, side effects such as muscle cramps, dizziness, and upper respiratory infections may occur. Rarely, serious side effects such as angioedema, hepatitis, myalgia, and hyperkalemia have been reported; if any abnormal symptoms occur, consult a healthcare professional immediately. It is important to regularly check blood pressure, kidney function, and blood electrolyte levels while on this medication. Particularly due to the risk of hyperkalemia, potassium supplements or potassium-containing salt substitutes should not be taken together. This medication can interact with some drugs, so inform your doctor or pharmacist if you are taking other medications. It is advisable to avoid grapefruit juice while taking this medication. Lactating women should avoid taking this medication or discontinue breastfeeding, and this medication should not be given to children under 6 years old. In cases of overdose, hypotension and bradycardia may occur, requiring immediate medical attention; this drug is not removed by dialysis. Dizziness or drowsiness may occur during this medication, so caution is advised when driving or operating machinery. Store this medication in a tightly closed container away from air or moisture, and do not transfer to other containers.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air and moisture. It is also recommended to keep it in a cool and dry place between 15 to 30 degrees Celsius.
White oval film-coated tablet
Domestic use: 30 tablets/bottle, 300 tablets/bottle; for export: 100 tablets (10 tablets/PTP x 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.